KalkineBell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum
Highlights Cogstate continues expanding its presence in neuroscience-focused clinical trials. Growing demand from biopharma customers and strategic partnerships are supporting business momentum. New opportunities in sleep disorders and psychiatry are helping diversify revenue sources. Cogstate continues building momentum through healthcare technology innovation, strategic partnerships and expanding opportunities across clinical research markets. Cogstate (ASX:CGS) has attracted renewed market...
ASX
Google News